Immunotherapy: past, present and future

Reviewer: Ryan P. Smith, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 4 de julio del 2004

Translation for this article does not exist


Click on any of these terms for more related articles


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

ASCO: PD-1 Immunotherapy Benefits Patients With NSCLC

Jun 1, 2015

Fewer side effects, longer survival for nivolumab versus docetaxel

AATS: Low Annual Hospital Volume Ups Mortality Past 30 Days

May 2, 2014

Findings in patients undergoing major pulmonary resection for lung cancer

AACR: Novel Treatments Show Promise for Ovarian Cancer

Apr 9, 2013

Two studies show benefits of two-step immunotherapy approach; experimental drug